Luffa-Lobelia comp. Heel, Tabletten

7680526800266 CH-52680 20.01.1.
Luffa-Lobelia comp. Heel, Tabletten
Luffa-Lobelia comp. Heel, Tabletten
Luffa-Lobelia comp. Heel, Tabletten
1 / 3
google

Details

Product number
5268001
CPT
-
Packaging group
250
Unit
Tablette(n)
Composition
luffa operculata (HAB) D12 25 mg, aralia racemosa (HAB) D1 25 mg, arsenum iodatum (HAB) D8 (HAB 5a) 25 mg, lobelia inflata (HAB) D6 25 mg, lactosum monohydricum, magnesii stearas, pro compresso 301.5 mg corresp. lactosum monohydricum 300 mg.

Articles (1)

Luffa-Lobelia comp. Heel, Tabletten
Tabletten
250
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/05/2024
Patient information leaflet
Français
22/05/2024
Patient information leaflet
Italien
22/05/2024

Detailed composition

Substance Quantity Type Category
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
300.0 MG Substance HBESI

Authorization holder

ebi-pharm ag

3038 Kirchlindach

Authorization information

Swissmedic authorization number
52680
Drug name
Luffa-Lobelia comp. Heel, Tabletten
Galenic form
TAB
Authorization status
Z
Dispensation category
D
First authorization
05/04/1994
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei Heuschnupfen.

Packaging details

Description (FR)
LUFFA-LOBELIA COMP Heel cpr bte 250 pce
Description (DE)
LUFFA-LOBELIA COMP Heel Tabl Ds 250 Stk
Narcotic (BTM)
No

Other packaging sizes

LUFFA-LOBELIA COMP Heel cpr bte 50 pce
50 TABL
View